Skip to content

The Novelty of Ayahuasca Scale and the prediction of intentions to use

Brianna R. Altman, Maha N. Mian, Mitch Earleywine

Journal of Psychedelic Studies March 12, 2020 DOI: 10.1556/2054.2020.00117 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Cross-sectional survey Peer reviewed
Sample size 139
Population Experienced hallucinogen users
Topics Ayahuasca LSD Psilocybin
Keywords Hallucinogen Novelty
Citations 4
Key findings Expectancies for ayahuasca differ from those for other hallucinogens and influence intentions to use ayahuasca again, with positive connection expectancies increasing and physical reaction expectancies decreasing future use intentions.

Abstract

Abstract Objective Given the growing popularity of ayahuasca and other hallucinogens, we sought to identify related expectancies and their role in why people might use this psychoactive brew rather than classic hallucinogens like LSD or psilocybin.

Method: Experienced users (N = 139) completed an online survey about their use of hallucinogens (including ayahuasca), how their ayahuasca experiences differed from those with other hallucinogens, as well as their intentions to use hallucinogens (including ayahuasca) in the future.

Results: Participants expected ayahuasca effects to differ meaningfully from the effects of other hallucinogens in multiple domains. Expected differences involved positive connections to nature (and other people), dramatic (or terrifying) thoughts, high variability of effects, and physical reactions. Intentions to use ayahuasca in the future increased as expectancies for positive connections increased, but decreased as physical reactions increased. One version of the full Novelty of Ayahuasca scale significantly covaried with the likelihood of using ayahuasca over other hallucinogens in the future, while another version did not. This result calls for further work examining how users perceive certain ayahuasca-induced effects.

Conclusions: These findings reveal that expectancies for ayahuasca differ from those for other hallucinogens, and impact an individual's willingness to try the substance again. Understanding these differences might help those who are interested in the therapeutic potential of hallucinogens decide among those available. Future studies might examine how these expectancies predict intentions to use ayahuasca (and other hallucinogens) longitudinally. Comparable approaches could also identify unique expectancies for other hallucinogens to see if those predict a preference for one over others.

Comparable studies

Other cross-sectional and survey studies on ayahuasca, most cited first.

Study Year Design Participants
Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT Adults reporting a single most memorable God encounter experience, either nondrug or... 2019 Cross-sectional survey n = 4,285
Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey. Ayahuasca users from more than 50 countries who completed an online survey 2022 Cross-sectional survey n = 10,836
Ayahuasca in adolescence: a preliminary psychiatric assessment. Adolescents from a Brazilian ayahuasca sect and matched controls 2005 Controlled cross-sectional study n = 80
Psychological and neuropsychological assessment of regular hoasca users. Regular hoasca users from a U.S. branch of União do Vegetal and matched non-user controls 2016 Cross-sectional study n = 57
Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey People with cluster headache 2015 Cross-sectional survey n = 496

Citations in the library

Explore topics